ENTITY
stringlengths 8
8
| DEFINITION
stringlengths 3
8.47k
⌀ | ALIASES
stringlengths 2
13.6k
⌀ | NAME
stringlengths 2
1.98k
|
|---|---|---|---|
C0268390 | An autoinflammatory disease caused by mutations in the NLRP3 gene which encodes cryopyrin. It is characterized by recurrent episodes of urticaria and fever which develop in infancy. It may lead to sensorineural hearing loss and/or amyloidosis. | Syndromes, UDA|MUCKLE-WELLS SYNDROME|Familial amyloid nephropathy with urticaria AND deafness|UDA Syndrome|muckle-wells syndrome|Urticaria-Deafness-Amyloidosis Syndrome|Urticaria Deafness Amyloidosis Syndrome|muckle well syndrome|UDA SYNDROME|Syndromes, Urticaria-Deafness-Amyloidosis|Urticaria, deafness and amyloidosis syndrome (Muckle and Wells)|URTICARIA-DEAFNESS-AMYLOIDOSIS SYNDROME|Familial amyloid nephropathy with urticaria AND deafness (disorder)|Amyloid nephropathy with deafness and urticaria|Muckle-Wells syndrome|Urticaria, Deafness and Amyloidosis|CAPS2|Muckle-Wells Syndrome|Muckle Wells Syndrome|Urticaria-Deafness-Amyloidosis Syndromes|Syndrome, Muckle-Wells|Muckle-Wells type amyloidosis|Syndrome, Urticaria-Deafness-Amyloidosis|MWS|CRYOPYRIN-ASSOCIATED PERIODIC SYNDROME 2|Familial amyloid nephropathy with urticaria and deafness|Syndrome, UDA|UDA Syndromes | Muckle-Wells Syndrome |
C0263338 | Wheals and/or angioedema presented with daily symptoms lasting for more than 6 weeks. It may be classified into chronic spontaneous and chronic inducible urticaria depending on whether a specific trigger can be linked to the development of vascular reaction. | Chronic urticaria (disorder)|Chronic urticaria|Urticaria, chronic|urticaria chronic|Chronic Urticarias|Urticaria, Chronic|Urticaria, recurrent periodic|Recurrent periodic urticaria|chronic urticaria | Chronic Urticaria |
C0391965 | null | Acladium castellani|Allescheria boydii|Pseudoallescheria boydii|Scedosporium boydii|pseudallescheria boydii|Pseudallescheria boydii|Petriellidium boydii|pseudoallescheria boydii|Cephalosporium boydii|Pseudallescheria boydii (organism)|Petriellidum boydii | Pseudallescheria boydii (fungus) |
C0011615 | A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. | Neurodermatitides, Atopic|DERMATITIS, ATOPIC|Atopic Neurodermatitides|ECZEMA ATOPIC|allergic dermatitis|Allergic dermatitis|Disseminated Neurodermatitis|atopic neurodermatitis|Atopic dermatitis, NOS|Constitutional eczema|Disseminated neurodermatitis|Atopic Dermatitis|Eczema, allergic|Atopic Neurodermatitis|Dermatitis, Atopic|Atopic neurodermatitis|besnier's prurigo|AD - Atopic dermatitis|ATOPIC DERMATITIS|Allergic eczema|Atopic eczema|NEURODERMATITIS, DISSEMINATED|allergic eczema|Allergic dermatitis (disorder)|endogenous eczema|Atopic dermatitis, chronic|ECZEMA, CONSTITUTIONAL|Neurodermatitis, Atopic|atopic dermatitis|Dermatitides, Atopic|atopic eczema|ECZEMA, ATOPIC|Canine atopy|ATOD|Dermatitis, atopic|Neurodermatitis, atopic|Atopic dermatitis (disorder)|Atopic neurodermatitis (disorder)|Atopic dermatitis|DERMATITIS ATOPIC|Neurodermatitides, Disseminated|Atopic Eczema|Atopic Dermatitides|Eczema, Atopic|DERMATITIS ALLERGIC|Eczema, atopic|constitutional eczema|Disseminated Neurodermatitides|Neurodermatitis, Disseminated | Dermatitis, Atopic |
C0151811 | A small palpable mass in the subcutaneous tissues. | Subcutaneous nodule, NOS|nodules subcutaneous|Subcutaneous nodules|Growth of abnormal tissue under the skin|NODULE SUBCUTANEOUS|Subcutaneous nodule (finding)|Subcutaneous nodule|Nodule of subcutaneous tissue, NOS|subcutaneous nodule|Firm lump under the skin|SUBCUTANEOUS NODULE|subcutaneous nodules|Subcutaneous Nodule|Nodule below the skin|Nodule of subcutaneous tissue | Subcutaneous nodule |
C0064113 | A triazole antifungal agent that inhibits cytochrome P-450-dependent enzymes required for ERGOSTEROL synthesis. | (+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one|3H-1,2,4-Triazol-3-one, 4-(4-(4-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-(1-methylpropyl)-|Itraconazolum|oriconazole|Oriconazole|Product containing itraconazole (medicinal product)|ITRACONAZOLE|Itraconazole-containing product|itraconazole|Itraconazole (substance)|Itraconazol|ICZ|Itraconazole | itraconazole |
C0079474 | An autosomal recessive allelic variant of epidermolysis bullosa dystrophica caused by mutation(s) in the COL7A1 gene, encoding collagen alpha-1(VII) chain. | RDEB|Recessive dystrophic epidermolysis bullosa|Epidermolysis bullosa dystrophica, recessive|DYSTROPHIC EPIDERMOLYSIS BULLOSA, AUTOSOMAL RECESSIVE|Epidermolysis Bullosa Dystrophica, Recessive|EPIDERMOLYSIS BULLOSA DYSTROPHICA, GENERALIZED SEVERE, AUTOSOMAL RECESSIVE|Hallopeau-Siemens Disease|EPIDERMOLYSIS BULLOSA DYSTROPHICA, HALLOPEAU-SIEMENS TYPE|Dermolytic bullous dermatosis, recessive|Dystrophic Epidermolysis Bullosa, Autosomal Recessive|EPIDERMOLYSIS BULLOSA DYSTROPHICA, AUTOSOMAL RECESSIVE|Epidermolysis Bullosa Dystrophica, Hallopeau-Siemens Type|Recessive Dystrophic Epidermolysis Bullosa|Hallopeau Siemens Disease|Polydysplastic epidermolysis bullosa|Epidermolysis Bullosa Dystrophica, Hallopeau Siemens Type|EBR1|Epidermolysis Bullosa Dystrophica, Autosomal Recessive|Dysplastic epidermolysis bullosa dystrophica|Recessive dystrophic epidermolysis bullosa (disorder) | Hallopeau-Siemens Disease |
C1519478 | Any mutation that occurs within the discrete sequences comprising the 5' or 3' splice sites of a gene that has a spliced message. Splice-site mutation may result in a deletion or insertion of extraneous amino acids in the gene product or a change in the reading frame of the spliced message. | Splice Region Variant|Splice-Juction Mutation|Splice-Site Mutation Abnormality|Intron Splice Site Mutation|Intronic Splice Site Mutation|Splice-Site Mutation | Splice-Site Mutation |
C0030489 | A group of related diseases characterized by an unbalanced or disproportionate proliferation of immunoglobulin-producing cells, usually from a single clone. These cells frequently secrete a structurally homogeneous immunoglobulin (M-component) and/or an abnormal immunoglobulin. | Paraproteinemia|Monoclonal hypergammaglobulinemia|paraproteinaemia|paraproteinemias|Paraproteinaemia|Paraimmunoglobulinemia|Paraimmunoglobulinemias|paraproteinemia|Paraproteinemias | Paraproteinemias |
C0015426 | Each of the upper and lower folds of SKIN which cover the EYE when closed. | Eyelid|Eyelid, NOS|palpebra|Set of eyelids|Eyelids set|Eyelid structure (body structure)|Palpebra|palpebral|Palpebrae|Blepharon|eyelids|eyelid|Eyelid structure|Palpebral|Eyelids|EYELID | Eyelid structure |
C0004600 | The rear surface of an upright primate from the shoulders to the hip, or the dorsal surface of tetrapods. | Back|back anatomy|back (body region)|Set of regions of back|Back of trunk|Regions of back|backs|regions of back|back regions|Dorsum of trunk|Back, NOS|back region|BACK|dorsum|back|Dorsum|Regiones dorsales | Back |
C0041582 | A lesion on the surface of the skin or a mucous surface, produced by the sloughing of inflammatory necrotic tissue. | ulcer|Ulcerative lesion, NOS|lesions ulcerative|ulcerates|Ulcer (disorder)|Ulceration, NOS|ulcers|ulcerated|ULCER|ulcerate|lesions ulcer|Ulceration|ulceration|Ulcers|ulcerating|ulcerative|Ulcerated|ulcerations|Ulcer (morphologic abnormality)|Ulcerative (qualifier value)|Ulcus, NOS|Ulcerating|Ulcerative lesion|ulcer lesion|Ulcer - lesion|Ulcer, NOS|ulceratives|Ulcerative|Ulcer|ULCERS|Ulcus|lesions ulcers | Ulcer |
C0229789 | A lymph node located adjacent to the lumbar region of the spine. | Paraaortic Lymph Node|Para-aortic lymph node|Left lateral aortic lymph node|LYMPH NODE, LUMBAR|Aortic lymph node|Lateral aortic lymph node|Lateral aortic node|Paraaortic lymph node|Lateral aortic lymph node group|Lateral aortic nodes|Lateral aortic lymph nodes set|lymph nodes paraaortic|para-aortic node|lymph nodes periaortic|Set of lateral aortic lymph nodes|Lateral aortic lymph nodes|PARA-AORTIC LYMPH NODE|aortic lymph node|Latero-aortic lymph node|lymph nodes para aortic|node para-aortic|periaortic lymph node|Lymph Node, Para-Aortic|Nodi lymphoidei aortici laterales|Aortic Lymph Node|Structure of aortic lymph node|para-aortic lymph node|Nodi aortici laterales|Lateroaortic lymph node|Periaortic lymph node|Structure of aortic lymph node (body structure)|aortic lymph nodes | Para-aortic node |
C0796494 | A portion of an organ, such as the liver, lung, breast, thyroid, or brain. | Anatomical lobe|lobe|Lobus|Lobe|lobes | lobe |
C0032950 | A glucocorticoid with the general properties of the corticosteroids. It is the drug of choice for all conditions in which routine systemic corticosteroid therapy is indicated, except adrenal deficiency states. | delta-hydrocortisone|delta(1)-Dehydrohydrocortisone|Delta1-dehydro-hydrocortisone|delta(1)hydrocortisone|Prednisolone|prednisolone|delta-dehydrocortisol|Delta(1)Hydrocortisone|delta1-dehydro-hydrocortisone|Metacortandralone|(11beta)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione|Hydroretrocortine|PREDNISOLONE|metacortandralone|1,4-pregnadiene-3,20-dione-11β,17α,21-triol|Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-|deltahydrocortisone|Prednisolone-containing product|PRDL|Prednisolone preparation|Prednisolona|1,2-dehydrohydrocortisone|Product containing prednisolone (medicinal product)|3,20-dioxo-11β,17α,21-trihydroxy-1,4-pregnadiene|Deltahydrocortisone|Deltahydrocortisone preparation|delta-dehydrohydrocortisone|Prednisolone (substance)|1,4-pregnadiene-11β,17α,21-triol-3,20-dione|Prednisolonum|delta(1)-Hydrocortisone|Metacortandralone preparation|delta(1)-Dehydrocortisol|1,2-Dehydrohydrocortisone|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|Delta-F|(11β)-11,17,21-trihydroxypregna-1,4-diene-3,20-dione|.delta.1-Hydrocortisone|prednisoLONE | prednisolone |
C0699319 | null | and cytoxan|Cytoxan | cytoxan |
C0699320 | null | endoxan | Endoxan |
C0699996 | null | leukeran|Leukeran | Leukeran |
C0259990 | Physicians specializing in MEDICAL ONCOLOGY or its sub-specialties of RADIATION ONCOLOGY or SURGICAL ONCOLOGY. | oncologist|oncologists|ONCOLOGIST|Oncologists|Oncologist | Oncologists |
C0007117 | A carcinoma involving the basal cells. | bcc|Basal Cell Carcinoma|Basal cell carcinoma|Basiloma|BASAL CELL CARCINOMA|Basal cell carcinoma (morphologic abnormality)|Rodent ulcer|BCC - Basal cell carcinoma|basal cell carcinoma | Basal cell carcinoma |
C0015450 | The anterior portion of the head that includes the skin, muscles, and structures of the forehead, eyes, nose, mouth, cheeks, and jaw. | FACE|facial|Face structure|facies|Facial|Face|face|Face structure (body structure)|Face, NOS|facials|Faces|faces|face structure|Face (volume)|Facies | Face |
C0262926 | A collection of information about a person's health. It may include information about allergies, illnesses and surgeries, and dates and results of physical exams, tests, screenings, and immunizations. It may also include information about medicines taken and about diet and exercise. | History of (contextual qualifier)|personal history|History of (contextual qualifier) (qualifier value)|History|Personal History|Medical History|History of|history of|personal health record|Personal Medical History|personal medical history|history|medical history of|PMH|General Medical History|medical history|Past Medical History | Medical History |
C0007102 | A primary or metastatic malignant neoplasm that affects the colon. Representative examples include carcinoma, lymphoma, and sarcoma. | Colon cancer|malignant neoplasm of colon|Malignant neoplasm of colon (disorder)|cancer colonic|Malignant Neoplasm of the Colon|ca colon|Cancers, Colon|cancer of the colon|Colon Tumor, Malignant|of the colon cancer|Malignant neoplasm of colon, unspecified|Cancer of colon|Malignant Colonic Tumor|Malignant tumour of colon|Colon Cancers|Colon Cancer|Cancer of the Colon|of cancer colon|colonic cancer|CA - Cancer of colon|cancer colons|COLON CANCER|Malignant Colon Neoplasm|Malignant neoplasm of colon, unspecified site|cancer of colon|Cancer of Colon|Malignant Colon Tumor|Malignant neoplasm of colon, NOS|Cancer, Colonic|Malignant neoplasm of colon|malignant colon neoplasm|Malignant colonic tumor|colon cancers|Malignant Colonic Neoplasm|Cancers, Colonic|Malignant Neoplasm of Colon|Colonic Cancer|Malignant tumor of colon|Malignant Tumor of Colon|colon ca|Cancer, Colon|Colon Neoplasm, Malignant|colon cancer|Malignant Tumor of the Colon|Colonic Cancers | Malignant tumor of colon |
C0242379 | A primary or metastatic malignant neoplasm involving the lung. | Malignant tumour of lung|Malignant Tumor of Lung|lung cancer|Lung Cancers|lung cancers|Cancers, Lung|Malignant lung tumors|Malignant tumor of lung (disorder)|Cancer of the Lung|CA - Lung cancer|cancer of the lung|cancer pulmonary|MALIGNANT LUNG NEOPLASM|Pulmonary Cancer|Malignant tumor of lung|malignant neoplasm lung|cancers lungs|Lung Cancer|pulmonary cancer|Cancers, Pulmonary|Lungs--Cancer|Pulmonary Cancers|Malignant neoplasm of lung, NOS|lung malignant tumors|Cancer of Lung|Malignant Neoplasm of the Lung|Malignant Tumor of the Lung|Malignant Lung Neoplasm|Lung cancer|lungs cancer|lung malignant tumours|Malignant Neoplasm of Lung|lung malignancies|Cancer, Pulmonary|malignant lung neoplasm|cancer of lung|Malignant Lung Tumor|lung malignancy|Cancer, Lung | Malignant neoplasm of lung |
C0229312 | A small curved flap of auricular cartilage on the external ear anterior to the concha and inferior to the crux of the helix. | Tragal part of pinna|Tragus structure|tragus|Tragus|Tragus structure (body structure) | Tragal part of pinna |
C0230003 | Midline anatomical point of skull representing the highest point of skull intersecting the midsagittal plane. | Vertex of head|vertex|top head|Vertex structure|top of head|head top|Top of head|Vertex structure (body structure)|vertex head|head of top|Vertex | Vertex |
C0332563 | A small, solid, usually inflammatory elevation of the skin that does not contain pus | papules|Papular|Skin papules|Papula|papulae|Papulae|Papule, NOS|papule|Papule|Papule (morphologic abnormality)|Papules | Papule |
C0921005 | A small lobe or subdivision of a lobe. | lobules|Lobulus|lobule|Lobule | Lobule |
C0334683 | A basal cell carcinoma of the skin that is characterized by sebaceous differentiation. | Basosebaceous Epithelioma|Basal cell carcinoma with sebaceous differentiation|Skin Basal Cell Carcinoma with Sebaceous Differentiation|Basal cell carcinoma with sebaceous differentiation (morphologic abnormality)|Basal Cell Epithelioma with Sebaceous Differentiation|Basal cell carcinoma with sebaceous differentiation (disorder)|Basal Cell Carcinoma with Sebaceous Differentiation|Sebaceous Epithelioma | Skin Basal Cell Carcinoma with Sebaceous Differentiation |
C0015420 | Curved rows of HAIR located on the upper edges of the eye sockets. | Supercilium|eyebrow|Eyebrows|Eyebrow structure (body structure)|Supercilia|Eyebrow structure|Set of eyebrows|Eyebrow|Eyebrows set|eyebrows | Eyebrow structure |
C0032952 | A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver. | Delta(1)-Cortisone|Pregna-1,4-diene-3,11,20-trione, 17,21-dihydroxy-|Prednisone preparation|Metacortandracin|Deltadehydrocortisone preparation|Deltadehydrocortisone|PREDNISONE|deltacortisone|Prednisone (substance)|1;2-dehydrocortisone|Delta 1-Cortisone|Prednisonum|1, 2-Dehydrocortisone|1,2-Dehydrocortisone|predniSONE|.delta.1-Cortisone|PRED|Prednisone|metacortandracin|1, 2-dehydrocortisone|prednisone|delta 1-cortisone|Prednisona|Dehydrocortisone|PRD|1,4-Pregnadiene-17α,21-diol-3,11,20-trione|Prednisone-containing product|Product containing prednisone (medicinal product)|Deltacortisone|17,21-dihydroxypregna-1,4-diene-3,11,20-trione|delta-Cortisone|deltadehydrocortisone|Deltacortisone preparation|17,21-Dihydroxypregna-1,4-diene-3,11,20-trione | prednisone |
C0817705 | null | left heel|Left heel|heel left | Left heel |
C0263478 | null | Ophiasic alopecia areata|ophiasis|Ophiasis|Ophiasis (disorder)|Alopecia areata, ophiasic | Ophiasis |
C0076110 | A synthetic allylamine derivative with antifungal activity. Terbinafine exerts its effect through inhibition of squalene epoxidase, thereby blocking the biosynthesis of ergosterol, an important component of fungal cell membranes. As a result, this agent disrupts fungal cell membrane synthesis and inhibits fungal growth. | Terbinafine-containing product|Terbinafine (substance)|TERBINAFINE|Terbinafina|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene Methanamine|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalenemethylamine|terbinafine|Product containing terbinafine (medicinal product)|Terbinafine|1-Naphthalenemethanamine, N-((2E)-6,6-dimethyl-2-hepten-4-yn-1-yl)-N-methyl-|(E)-N-(6,6-Dimethyl-2-hepten-4-ynyl)-N-methyl-1-naphthalene methanamine|Terbinafinum | terbinafine |
C0409974 | A chronic inflammatory connective tissue disease marked by skin rashes, joint pain and swelling, inflammation of the kidneys, inflammation of the fibrous tissue surrounding the heart (i.e., the pericardium), as well as other problems. Not all affected individuals display all of these problems. | Lupus erythematosus|Lupus|LE - Lupus erythematosus|Lupus Erythematosus|lupus erythematosus|Lupus erythematosus (disorder)|lupus | Lupus Erythematosus |
C0007194 | A form of CARDIAC MUSCLE disease, characterized by left and/or right ventricular hypertrophy (HYPERTROPHY, LEFT VENTRICULAR; HYPERTROPHY, RIGHT VENTRICULAR), frequent asymmetrical involvement of the HEART SEPTUM, and normal or reduced left ventricular volume. Risk factors include HYPERTENSION; AORTIC STENOSIS; and gene MUTATION; (FAMILIAL HYPERTROPHIC CARDIOMYOPATHY). | hypertrophic myocardiopathy|CARDIOMYOPATHY, HYPERTROPHIC|hocm|Cardiomyopathies, Hypertrophic|hypertrophic cardiomyopathy (HCM)|cardiomyopathy hypertrophic|Hypertrophic Cardiomyopathies|obstructive cardiomyopathy|Enlarged and thickened heart muscle|HCM - Hypertrophic cardiomyopathy|Cardiomyopathy, hypertrophic|Hypertrophic cardiomyopathy (disorder)|Hypertrophic cardiomyopathy|Hypertrophic Cardiomyopathy|Cardiomyopathy, Hypertrophic|hypertrophic cardiomyopathy | Hypertrophic Cardiomyopathy |
C0030252 | A rapid or irregular heartbeat that a person can feel. | Palpitation|heart throbbing|HEART THROBBING|Palpitation(s)|palpitations|PALPITATION|heart throb|palpitation|Heart palpitations|Palpitations (finding)|PALPITATIONS|Palpitations | Palpitations |
C0700200 | An episode of lightheadedness and dizziness which may precede an episode of syncope. | NEAR SYNCOPE|presyncope|Presyncopes|PRESYNCOPE|pre syncope|pre-syncope|Presyncope|Near syncope|near syncope|Near syncope (disorder) | Presyncope |
C0199551 | null | Study, Cardiac Electrophysiologic|Cardiac Electrophysiologic Study|EPS|Electrophysiologic Study, Cardiac|Cardiac Electrophysiologic Studies|Cardiac electrophysiologic stimulation and recording study, NOS|Catheter based invasive electrophysiologic testing|Electrophysiologic studies|Cardiac electrophysiologic stimulation and recording study|cardiac electrophysiologic study|cardiac electrophysiologic stimulation and recording study|electrophysiologic studies|Electrophysiologic Studies, Cardiac|Cardiac electrophysiologic stimulation and recording study (procedure)|Studies, Cardiac Electrophysiologic|electrophysiologic study | Cardiac electrophysiologic stimulation and recording study |
C0949216 | Therapies are termed as Alternative when used instead of conventional treatment. | Therapy, Alternative|alternative therapy|Therapies, Alternative|alternative therapies|Alternative Therapies | Alternative Therapies |
C1142166 | An autosomal dominant defect of cardiac conduction that is characterized by an abnormal ST-segment in leads V1-V3 on the ELECTROCARDIOGRAM resembling a right BUNDLE-BRANCH BLOCK; high risk of VENTRICULAR TACHYCARDIA; or VENTRICULAR FIBRILLATION; SYNCOPAL EPISODE; and possible sudden death. This syndrome is linked to mutations of gene encoding the cardiac SODIUM CHANNEL alpha subunit. | Brugada syndrome|Brugada syndrome (disorder)|RIGHT BUNDLE BRANCH BLOCK, ST SEGMENT ELEVATION, AND SUDDEN DEATH SYNDROME|SUNDS|brugadas syndrome|Right Bundle Branch Block, ST Segment Elevation, and Sudden Death Syndrome|Brugada Syndrome|Sudden Unexplained Death Syndrome|Sudden Unexplained Nocturnal Death Syndrome|SUDDEN UNEXPLAINED NOCTURNAL DEATH SYNDROME|Sudden Unexplained Nocturnal Death Syndrome (SUNDS)|brugada syndrome | Brugada Syndrome (disorder) |
C0055729 | A quinoline and tetrazole derivative that acts as a phosphodiesterase type 3 inhibitor, with anti-platelet and vasodilating activity. It is used in the treatment of PERIPHERAL VASCULAR DISEASES; ISCHEMIC HEART DISEASE; and in the prevention of stroke. | 6-[4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone|6-[4-(1-Cyclohexyl-1H-tetrazol-5-yl)-butoxy]-3,4-dihydro-1H-quinolin-2-one|Cilostazol (substance)|cilostazol|2(1H)-Quinolinone, 6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-|Cilostazole|3,4-dihydro-6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-2(1H)-quinolinone|Cilostazol-containing product|Cilostazolum|6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydrocarbostyril|CILOSTAZOL|Product containing cilostazol (medicinal product)|6-(4-(1-cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone|Cilostazol|6-(4-(1-Cyclohexyl-1H-tetrazol-5-yl)butoxy)-3,4-dihydro-2(1H)-quinolinone | cilostazol |
C0042510 | A potentially lethal cardiac arrhythmia that is characterized by uncoordinated extremely rapid firing of electrical impulses (400-600/min) in HEART VENTRICLES. Such asynchronous ventricular quivering or fibrillation prevents any effective cardiac output and results in unconsciousness (SYNCOPE). It is one of the major electrocardiographic patterns seen with CARDIAC ARREST. | Cardiac arrest and ventricular fibrillation|Ventricular Fibrillations|Ventricular fibrillation (disorder)|Fibrillations, Ventricular|ventricular fibrillation|VENTRICULAR FIBRILLATION|Ventricular fibrillation|VENTRICULAR FIBRILLATION PAROXYSM|Cardiac arrest - ventricular fibrillation|FIBRILLATION PAROXYSMAL VENT|VF|VF - Ventricular fibrillation|vf|Fibrillation, Ventricular|FIBRILLATION VENTRICULAR|VFib|Ventricular Fibrillation|fibrillation ventricular | Ventricular Fibrillation |
C0442016 | null | Epicardial (qualifier value)|epicardial|Epicardial | Epicardial |
C0031638 | Compounds which inhibit or antagonize the biosynthesis or actions of phosphodiesterases. | Phosphoric Diester Hydrolase Inhibitors|Phosphodiesterase inhibitor-containing product|Substance with phosphodiesterase inhibitor mechanism of action|phosphodiesterase inhibitors|Phosphodiesterase inhibitor|Antiphosphodiesterases|Product containing phosphodiesterase inhibitor (product)|Phosphodiesterase Inhibitors|Phosphodiesterase Antagonists|Substance with phosphodiesterase inhibitor mechanism of action (substance)|PDE Inhibitor|phosphodiesterase inhibitor|Phosphodiesterase Inhibitor | Phosphodiesterase Inhibitors |
C0185003 | A repair that unites structures | Closure|CLOSURES|Closure, NOS|Closure - action|Reparative closure (procedure)|Closure - action (qualifier value)|Surgical closure|surgical closure|Surgical closure, NOS|Reparative closure | Reparative closure |
C0547070 | Removal, separation, detachment, extirpation, or eradication of a body part, pathway, or function by surgery, chemical destruction, morbid process, or noxious substance. | Catheter Ablation|Ablation Therapy|Local Ablative Therapy|Ablation, NOS|Ablation - action|Ablation - action (qualifier value)|ABLATION|Ablation|ablation|Local Ablation Therapy | Ablation |
C0034090 | The veins that return the oxygenated blood from the lungs to the left atrium of the heart. | Pulmonary veins|VEIN, PULMONARY|Pulmonary veins set|PULMONARY VEINS|Pulmonary Veins|Pulmonary venous structure|Pulmonary vein|Venae pulmonales|Pulmonary venous tree organ part|Veins, Pulmonary|Structure of vein of pulmonary circulation (body structure)|pulmonary vein|Pulmonary venous tree (organ part)|Structure of vein of pulmonary circulation|Set of pulmonary veins|Pulmonary Vein|Vein of lung|Vein, Pulmonary|pulmonary veins | Pulmonary veins |
C0003641 | A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) | Bovine Pancreatic Trypsin Inhibitor|Aprotinin|BPTI|Aprotinin Bovine|Trypsin Inhibitor, Kunitz, Pancreatic|Bovine Kunitz Pancreatic Trypsin Inhibitor|Basic Pancreatic Trypsin Inhibitor|BPTI, Basic Pancreatic Trypsin Inhibitor|Trypsin Inhibitor, Basic, Pancreatic|BPTI (bovine pancreatic trypsin inhibitor)|Aprotinin (substance)|Kunitz Pancreatic Trypsin Inhibitor|Aprotinin-containing product|aprotinin bovine|Aprotinin (bovine)|Trypsin Inhibitor, Pancreatic Basic|Kallikrein Trypsin Inactivator|Product containing aprotinin (medicinal product)|Bovine Aprotinin|Inactivator, Kallikrein-Trypsin|aprotinin|APROTININ|Aprotinin Biosynthetic|Kallikrein-Trypsin Inactivator|Aprotinina|Aprotinin Concentrated Solution | aprotinin |
C1328851 | null | blood forming organ | blood forming organ |
C0079105 | null | Ictalurus punctatus (organism)|Channel Catfish|Ictalurus punctatus|Channel Catfishes|Silurus punctatus|Catfish, Channel|Catfishes, Channel|Channel catfish | Catfishes, Channel |
C0301872 | Any immune system process that functions in the calibrated response of an organism to a potential internal or invasive threat. [GO_REF:0000022, GOC:add, GOC:mtg_15nov05] | Host response|Host response, function (observable entity)|Immune Response|Immune response|Immune response, function (observable entity)|immune response|immune responses|Immune response, NOS|Immune response, function|immunoresponse|host response|Host response, function|Immune Response Process | Immune response |
C1018109 | null | null | Loma salmonae |
C0150141 | The immersion or washing of the body or any of its parts in water or other medium for cleansing or medical treatment. It includes bathing for personal hygiene as well as for medical purposes with the addition of therapeutic agents, such as alkalines, antiseptics, oil, etc. | Bath|bath|Bathing|bathing|bathed|Baths|baths|Bathe | Bathing |
C0314829 | A species of facultatively anaerobic, Gram negative, rod shaped bacteria assigned to the phylum Proteobacteria. This bacteria is non motile, capable of both aerobic and anaerobic respiration, ferments glucose and is generally oxidase positive. A. solmonicida is found in freshwater and marine environments and causes furunculosis in fish and bald sea urchin disease. | Bacterium salmonicida|Bacillus salmonicida|Aeromonas salmonicida|Aeromonas salmonicida (organism)|AEROMONAS SALMONICIDA|Proteus salmonicida | Aeromonas salmonicida |
C0019053 | Proteins from BACTERIA and FUNGI that are soluble enough to be secreted to target ERYTHROCYTES and insert into the membrane to form beta-barrel pores. Biosynthesis may be regulated by HEMOLYSIN FACTORS. | Haemolysin|haemolysin|hemolysins|Proteins, Hemolysin|hemolysin|Hemolysin|Hemolysins|Haemolysin, NOS|Hemolysin, NOS|Hemolysin (substance)|Hemolysin Proteins|Hemalysins | Hemolysin |
C0003324 | Antigens expressed primarily on the membranes of living cells during sequential stages of maturation and differentiation. As immunologic markers they have high organ and tissue specificity and are useful as probes in studies of normal cell development as well as neoplastic transformation. | differentiation antigens|Differentiation Antigens|differentiation antigen|Antigens, Marker|Differentiation Markers|Antigens, Differentiation|Markers, Differentiation|Marker Antigens | Differentiation Antigens |
C0010150 | A species of gram-positive, asporogenous bacteria in which three cultural types are recognized. These types (gravis, intermedius, and mitis) were originally given in accordance with the clinical severity of the cases from which the different strains were most frequently isolated. This species is the causative agent of DIPHTHERIA. | Bacillus diphtheriae|Mycobacterium diphtheriae|Corynebacterium diphtheriae (organism)|Klebs-Loeffler bacillus|Bacterium diphtheriae|Microsporon diphthericum|Pacinia loeffleri|Microsporon diphtheriticum|Diphtheria bacillus|C. diphtheriae|CORYNEBACTERIUM DIPHTHERIAE|Corynebacterium diphtheriae | Corynebacterium diphtheriae |
C0027126 | Neuromuscular disorder characterized by PROGRESSIVE MUSCULAR ATROPHY; MYOTONIA, and various multisystem atrophies. Mild INTELLECTUAL DISABILITY may also occur. Abnormal TRINUCLEOTIDE REPEAT EXPANSION in the 3' UNTRANSLATED REGIONS of DMPK PROTEIN gene is associated with Myotonic Dystrophy 1. DNA REPEAT EXPANSION of zinc finger protein-9 gene intron is associated with Myotonic Dystrophy 2. | Dystrophia Myotonica|Myotrophia dystonica|Atrophicas, Myotonia|Myotonia Atrophicas|Myotonic dystrophy|CURSCHMANN-BATTEN-STEINERT SYNDROME|syndrome steinert|myotonia atrophica|Dystrophia Myotonicas|Myotonic Dystrophy|MYOTONIC MUSCULAR DYSTROPHY|Myotonic Dystrophies|Disease, Steinert's|DYSTROPHY, MYOTONIC|Steinert myotonic dystrophy syndrome (disorder)|Steinert Myotonic Dystrophy|muscular dystrophy myotonic|Dystrophies, Myotonic|myotonia dystrophica|dystrophia myotonica|dystrophy muscular myotonic|Myotonia Dystrophicas|Myotonic Dystrophy 1|dystrophy myotonic|MYOTONIA ATROPHICA|Dystrophicas, Myotonia|Steinert Disease|myotonic muscular dystrophy|DM - Dystrophia myotonica|Dystrophy, Myotonic|steinert disease|Myotonic Dystrophy, Steinert|Steinert myotonic dystrophy syndrome|Myotonia Atrophica|Myotonic muscular dystrophy|myotonic dystrophy|disease steinerts|STEINERT DISEASE|steinert's disease|Myotonia Dystrophica|Dystrophia myotonica|steinert syndrome|Myotonica, Dystrophia|Myotonicas, Dystrophia|Myotonia atrophica|Myotonia dystrophica|Dystrophica, Myotonia|Steinert's disease|Disease, Steinert|Steinert syndrome|Steinert's Disease|Dystrophy, Steinert Myotonic|Steinerts Disease|Atrophica, Myotonia|Dystrophia Myotonica 1 | Myotonic Dystrophy |
C0596508 | Cells derived from the BLASTOCYST INNER CELL MASS which forms before implantation in the uterine wall. They retain the ability to divide, proliferate and provide progenitor cells that can differentiate into specialized cells. | es cell|ES cell|Cell, Embryonic Stem|Embryonic Stem Cells|Embryonic stem cell|cells embryonic stem|embryonic stem cell|cell embryonic stem|Stem Cell, Embryonic|Embryonic stem cell (cell)|Embryonic Stem Cell|Stem Cells, Embryonic|Cells, Embryonic Stem|Embryonic stem cells | Embryonic Stem Cells |
C1328818 | A modified epithelial cell of the capsular epithelium of the renal glomerulus. It has a small perikaryon and a number of primary and secondary foot-like radiating processes (pedicels) that interdigitate with those of other podocytes and embrace the basal lamina of glomerular capillaries. | Epithelial Cells, Glomerular Visceral|visceral glomerular epithelial cell|Glomerular Visceral Epithelial Cells|Visceral Epithelial Cell|glomerular visceral epithelial cell|Podocyte|podocyte|Visceral Epithelial Cells, Glomerular | Podocytes |
C0021701 | A family of transmembrane glycoproteins (MEMBRANE GLYCOPROTEINS) consisting of noncovalent heterodimers. They interact with a wide variety of ligands including EXTRACELLULAR MATRIX PROTEINS; COMPLEMENT, and other cells, while their intracellular domains interact with the CYTOSKELETON. The integrins consist of at least three identified families: the cytoadhesin receptors(RECEPTORS, CYTOADHESIN), the leukocyte adhesion receptors (RECEPTORS, LEUKOCYTE ADHESION), and the VERY LATE ANTIGEN RECEPTORS. Each family contains a common beta-subunit (INTEGRIN BETA CHAINS) combined with one or more distinct alpha-subunits (INTEGRIN ALPHA CHAINS). These receptors participate in cell-matrix and cell-cell adhesion in many physiologically important processes, including embryological development; HEMOSTASIS; THROMBOSIS; WOUND HEALING; immune and nonimmune defense mechanisms; and oncogenic transformation. | integrins|integrin|RGD Receptor|Integrin Receptor|Extracellular Matrix, Integrins|Integrins|Integrin | Integrins |
C0008038 | Tobacco, in the form of a plug, usually flavored, for chewing rather than smoking. | tobacco oral|Oral tobacco|Tobacco, Oral|oral tobacco|chew tobacco|Oral Tobacco|Chewing tobacco|tobacco chew|Tobaccos, Chewing|Tobacco, Chewing|Spit Tobacco|chewing tobacco|Chewing Tobacco|Chewing Tobaccos|Chewing tobacco (substance)|Tobacco, chewing | Oral Tobacco |
C0054943 | Zinc-binding metalloproteases that are members of the type II integral membrane metalloproteases. They are expressed by GRANULOCYTES; MONOCYTES; and their precursors as well as by various non-hematopoietic cells. They release an N-terminal amino acid from a peptide, amide or arylamide. | aminopeptidase N|CD13 Antigens|Particle-bound aminopeptidase|Alanine aminopeptidase|CD13 Antigen|ANPEP|CD13 - Cluster of differentiation antigen 13|CD13|Lymphocyte antigen CD13 (substance)|Microsomal aminopeptidase|Aminopeptidase M|aminopeptidase n|Alanyl Aminopeptidase|alanine aminopeptidase|aminopeptidase m|Lymphocyte antigen CD13|AAP|Antigens, CD13|Antigen, CD13|Alanine Aminopeptidase|Membrane Alanyl Aminopeptidase|Aminopeptidase N | ALANINE AMINOPEPTIDASE |
C0376449 | Paired, segmented masses of MESENCHYME located on either side of the developing spinal cord (neural tube). Somites derive from PARAXIAL MESODERM and continue to increase in number during ORGANOGENESIS. Somites give rise to SKELETON (sclerotome); MUSCLES (myotome); and DERMIS (dermatome). | Somite|somites|somite | Somites |
C0113214 | A group of desmosomal cadherins with cytoplasmic tails that are divergent from those of classical CADHERINS. Their intracytoplasmic domains bind PLAKOGLOBIN; PLAKOPHILINS; and DESMOPLAKINS. | desmocollin | Desmocollins |
C0113216 | A group of desmosomal cadherins with cytoplasmic tails that resemble those of classical CADHERINS. | Desmoglein | Desmogleins |
C1564906 | A single-pass transmembrane glycoproteins that mediate CALCIUM-dependent CELL ADHESION and are core components of DESMOSOMES. | Cadherins, Desmosomal | Desmosomal Cadherins |
C0020678 | Presence of less than the normal amount of hair. (Dorland, 27th ed) | Hypotrichoses|Hair thinning|Hair thin|Hypotrichosis (disorder)|Scanty hair|HYPOTRICHOSIS|Hair scanty|Hypotrichosis, NOS|Hypotrichosis|hypotrichosis|Hypotrichosis NOS | Hypotrichosis |
C1571705 | Any small spherical group of cells containing a cavity. | Follicular|follicle|Follicle | Follicle |
C1282622 | null | Entire hair cortex|Entire hair cortex (body structure) | Entire hair cortex |
C0026503 | An order of egg-laying mammals that includes the PLATYPUS and ECHIDNA. | Egg-laying mammal|Monotrematas|Egg-laying mammal, NOS|Monotreme|Monotremes|Monotremata|Order Monotremata|ORDER MONOTREMATA - EGG-LAYING MAMMALS|Order Monotremata (organism) | Monotremata |
C1282778 | null | Entire epicondyle|Entire epicondyle (body structure) | Entire epicondyle |
C0263843 | null | hip snapping|snapping hip disorder|hip snapping syndrome|snap hip|band iliotibial syndromes|Snapping hip|Perrin-Ferraton disease|hips snapping|Snapping hip (disorder)|iliotibial band syndrome|Snapping hip syndrome|snapping hip syndrome|Perrin-Perraton disease|snapping hip | Snapping hip |
C0565514 | The use of compression dressings or garments to prevent or treat any of various conditions. | compression therapy|Compression Therapy|compression action | Compression procedure |
C1281592 | null | Entire neck|Entire neck (body structure) | Entire neck |
C1550319 | null | null | Vault |
C0024803 | null | null | Mariana Islands |
C0024803 | null | null | Mariana Islands |
C0024803 | null | null | Mariana Islands |
C0024803 | null | null | Mariana Islands |
C0872193 | null | immunoreaction | immunoreaction |
C0020268 | The main glucocorticoid secreted by the ADRENAL CORTEX. Its synthetic counterpart is used, either as an injection or topically, in the treatment of inflammation, allergy, collagen diseases, asthma, adrenocortical deficiency, shock, and some neoplastic conditions. | Hydrocortisone preparation|hydrocortisone|cortisols|Cortisol preparation|Hydrocortisone (substance)|11beta-hydrocortisone|HYDROCORTISONE|Hydrocortisone|Hydrocortisone-containing product|therapeutic hydrocortisone|4-pregnen-11β,17α,21-triol-3,20-dione|(11β)-11,17,21-trihydroxypregn-4-ene-3,20-dione|17-hydroxycorticosterone|HC|Hydrocortisonum|Product containing hydrocortisone (medicinal product)|(11beta)-11,17,21-Trihydroxypregn-4-ene-3,20-dione|hydrocortisones|cortisol|Compound F preparation|Hidrocortisona|Compound F|17-Hydroxycorticosterone|11β-hydrocortisone|Cortisol|Pregn-4-ene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-|Therapeutic Hydrocortisone|11beta,17alpha,21-Trihydroxy-4-pregnene-3,20-dione|Domolene | hydrocortisone |
C0042866 | A vitamin that includes both CHOLECALCIFEROLS and ERGOCALCIFEROLS, which have the common effect of preventing or curing RICKETS in animals. It can also be viewed as a hormone since it can be formed in SKIN by action of ULTRAVIOLET RAYS upon the precursors, 7-dehydrocholesterol and ERGOSTEROL, and acts on VITAMIN D RECEPTORS to regulate CALCIUM in opposition to PARATHYROID HORMONE. | Vitamin D and vitamin D derivative|Vitamin D preparation, NOS|VITAMIN D|Vitamin D NOS|Vitamin D, NOS|Vitamin D and vitamin D derivative-containing product|vitamin D|Vitamin D and vitamin D derivative (substance)|d vitamin|Vitamin D|Calciferol|Oleovitamin D preparation|Vitamin D, unspecified form|Product containing vitamin D and vitamin D derivative (product)|VITAMIN D PREPARATIONS|vitamin-d|vitamin d preparations|Calciotropic hormone|Oleovitamin D|vit d | vitamin D |
C0020962 | The body's defense mechanism against foreign organisms or substances and deviant native cells. It includes the humoral immune response and the cell-mediated response and consists of a complex of interrelated cellular, molecular, and genetic components. | Immune Systems|allergic/immunologic body system|Structure of immune system|organ system, allergic/immunologic|immune systems|body system, allergic/immunologic|Structure of immune system (body structure)|Immune system structure|Systems, Immune|Immune System|allergic/immunologic organ system|Immune system|immune system|immunologic/allergic organ system|System, Immune | Immune system |
C0276096 | null | MMA|Mastitis-metritis-agalactia syndrome (disorder)|Mastitis-metritis-agalactia syndrome | Mastitis-metritis-agalactia syndrome |
C1007755 | null | null | Phascogale calura |
C0003964 | The serous fluid of ASCITES, the accumulation of fluids in the PERITONEAL CAVITY. | Peritoneal effusion|Peritoneal Effusions|Fluids, Peritoneal|Ascitic Fluid|Ascitis|ascitic fluid|ascitis|peritoneal fluid|ascities|Peritoneal Effusion|Effusions, Peritoneal|Peritoneal fluid|Ascitic Fluids|Ascitic fluid (substance)|Peritoneal Fluids|Portion of peritoneal fluid|Fluid, Peritoneal|fluid peritoneal|peritoneal effusion|Peritoneal fluid (substance)|Ascitic fluid|Effusion, Peritoneal|PERITONEAL FLUID|Fluid, Ascitic|FLUID, PERITONEAL|Peritoneal Fluid|Fluids, Ascitic | Peritoneal Fluid (body substance) |
C1149836 | Catalysis of the hydrolysis of a lipid or phospholipid. [GOC:mah] | lipase activity | lipase activity |
C0030305 | INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. | Pancreatitis NOS|pancreas Inflammation|Pancreatitis, NOS|PANCREATITIS|pancreatitis|Pancreatic inflammation|Inflammation of pancreas|Pancreas inflamed|Pancreatitis (disorder)|Pancreatitis | Pancreatitis |
C0459385 | null | Brain tissue structure (body structure)|Brain tissue structure | Brain tissue |
C0003847 | The smallest divisions of the arteries located between the muscular arteries and the capillaries. | Arteriola|Structure of arteriole (body structure)|Arteriole|arteriole|arterioles|Structure of arteriole|Arterioles|Arteriole, NOS | Structure of arteriole |
C1176316 | A drug used to treat erectile dysfunction. It is also being studied in the treatment of sexual problems in patients treated with radiation or surgery for prostate cancer. Tadalafil blocks the action of a certain enzyme, which can result in increased blood flow to the penis, causing an erection. It is a type of cGMP phosphodiesterase type 5 (PDE5) inhibitor. | (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadalafilo|tadalafil|(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-|Tadalafil-containing product|Product containing tadalafil (medicinal product)|Tadalafil (substance)|TADALAFIL|Tadalafil | tadalafil |
C1318700 | Compounds that specifically inhibit PHOSPHODIESTERASE 5. | Substance with phosphodiesterase 5 inhibitor mechanism of action (substance)|PDE5 Inhibitors|Inhibitors, PDE5|Inhibitors, Phosphodiesterase 5|Substance with phosphodiesterase 5 inhibitor mechanism of action|PDE5 Inhibitor|PDE 5 Inhibitors|PDE-5 Inhibitors|PDE-V Inhibitor|Phosphodiesterase 5 inhibitor-containing product|5 inhibitors phosphodiesterase|Phosphodiesterase Type 5 Inhibitors|Phosphodiesterase V Inhibitor|pde 5 inhibitor|Phosphodiesterase 5 inhibitor|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitor|Inhibitors, PDE-5|Product containing phosphodiesterase 5 inhibitor (product) | Phosphodiesterase 5 inhibitor |
C0040578 | The cartilaginous and membranous tube descending from the larynx and branching into the right and left main bronchi. | Tracheal|Tracheal structure|Tracheas|trachea|Tracheal structure (body structure)|Trachea/Tracheal|Trachea|Tracheo-|Windpipe|Trachea, NOS|TRACHEA|windpipe | Trachea |
C0030054 | An element with atomic symbol O, atomic number 8, and atomic weight [15.99903; 15.99977]. It is the most abundant element on earth and essential for respiration. | O<sub>2</sub>|Oxygen, NOS|Oxygen|O2|Oxygen USP|O|Elemental oxygen|Chemical oxygen|Oxygen-16|Oxygen-containing product|oxygen|OXYGEN|O element|o 2|Pure oxygen|Oxygen 16|Product containing oxygen (medicinal product)|O2 element|Oxygen (substance)|O>2<|O2 - oxygen | oxygen |
C0967376 | null | cialis|Cialis | Cialis |
C1176316 | A drug used to treat erectile dysfunction. It is also being studied in the treatment of sexual problems in patients treated with radiation or surgery for prostate cancer. Tadalafil blocks the action of a certain enzyme, which can result in increased blood flow to the penis, causing an erection. It is a type of cGMP phosphodiesterase type 5 (PDE5) inhibitor. | (6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Tadalafilo|tadalafil|(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3- benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-|Tadalafil-containing product|Product containing tadalafil (medicinal product)|Tadalafil (substance)|TADALAFIL|Tadalafil | tadalafil |
C1319065 | A male individual who has had his testicles removed. | Neutered|Castrated male (finding)|Castrated Male|Neutered Male|Neutered male | Castrated male |
C0014930 | Compounds which inhibit or antagonize the action or biosynthesis of estrogenic compounds. | Estrogen Inhibitor|estrogen inhibitor|Estrogen Antagonists|antiestrogen|Antiestrogen Therapy Agent|antioestrogen|Antiestrogen|Product containing estrogen receptor antagonist (product)|Estrogen receptor antagonist-containing product|antiestrogenic|estrogen blocker|estrogen inhibitors|Antiestrogens/Modifiers|Anti-estrogens|Antiestrogen Therapy|Antiestrogenic|Estrogen--Antagonists|Estrogen Antagonist|Anti-Estrogens|antiestrogens|Antiestrogens|Antagonists, Estrogen | Estrogen Antagonists |
Subsets and Splits
No saved queries yet
Save your SQL queries to embed, download, and access them later. Queries will appear here once saved.